Status:
COMPLETED
Sedation Complications in Urology During Spinal Anesthesia With Dexmedetomidine or Midazolam Regarding OSA Risk
Lead Sponsor:
University Hospital of Split
Conditions:
Anesthesia
Anesthesia Complication
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
Light to moderate sedation is recommended during surgery with spinal anesthesia . This study is exploring which sedation drug is better, midazolam or dexmedetomidine for transurethral resection of bla...
Detailed Description
All participants were premedicated with diazepam 5mg 12 hours and 1 hour before surgery. Thromboprophylaxis (enoxaparin 4000-6000 IU) depending on the body weight was given at least 12 hours before su...
Eligibility Criteria
Inclusion
- elective transurethral resection of bladder and prostate
- American Society of Anesthesiologists (ASA) physical status classification system: I, II, III
Exclusion
- regional anesthesia contraindications
- American Society of Anesthesiologists (ASA) physical status classification system: IV
- Atrioventricular cardiac block II and III degree
- Psychotic disorders
- Participants with tracheostomy
- Dementia
- Allergy on Dexmedetomidine or Midazolam
Key Trial Info
Start Date :
April 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2022
Estimated Enrollment :
115 Patients enrolled
Trial Details
Trial ID
NCT04817033
Start Date
April 1 2021
End Date
February 1 2022
Last Update
April 8 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Split
Split, Croatia, 21000